Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Mabel Ryder, M.D. Endocrinologist, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ask Mayo Clinic: Thyroid Cancer
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Global Health Leadership in the Private Sector - a conversation with Medistim CEO Kari E. Krogstad - Kari E. Krogstad, CEO, Medistim
00:10:00
Tembo Gold's Tanzania Project and Future Plans with Barrick
00:10:00
Unveiling Commodity Connections: Tariq Dennison and APM Capital on Soybean & WTI Strategies | Tariq Dennison – Wealth Manager & Author
00:10:00
Strategies for Navigating Financial Markets Amidst Uncertainty | Katie Koch, CEO , TCW Group.
00:10:00
Artem Volynets Talks ACG SPAC Launch and Opportunity in New Economy Metals | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
Anastasia Amoroso, iCapital's Chief Investment Strategist, joins 'Squawk Box' to discuss recent market trends and insights from the Fed's latest decisions.
00:10:00
Revolutionizing Biotechnology: The Impact of Directed Evolution Technology on Protein Skins
00:10:00
Billionaire Hedge Fund Manager David Tepper to Return Outside Capital and Transition Appaloosa Management to Family Office, Reports Bloomberg
00:10:00
The video outlines Axiom's views, emphasizing their potential for change, the risks of investment, and that statements made are for informational purposes only and not guarantees of future performance.
00:10:00
Wiser Welcomes Matthews Barnett, CFP, ChFC, CLU
00:10:00
Ideas with significant upside or a significantly better mousetrap|Alexander Morgan,Partner,Khosla Ventures
00:10:00
Global Atomic Corporation: Advancing High-Grade Uranium and Zinc Projects